Keep up with all the latest news about how TEDCO is helping grow the Maryland entrepreneur funding sector through investments, network of industry professionals, and educational resources.
News & Events
TEDCO in the News
Another early winner picked by TEDCO’s Maryland Investment Initiative, this JHU-spinout continues to focus on its mission to treat vision loss
Baltimore biopharmaceutical company AsclepiX Therapeutics Inc. is developing therapies to target eye diseases.
LEARN MORE
AsclepiX Therapeutics Raises $5M in New Funding
MII portfolio company Asclepix Therapeutics raised over $5 million in new funding that will assist in development of new treatment for eye diseases that are leading causes of blindness in adults.
LEARN MORE
Maryland Stem Cell Research Fund's Seraxis publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy
SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes.
LEARN MORE
Longeveron Wins $6.7 Million in Grant Funding, Including a $750,000 TEDCO Award
Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related diseases. The company is focused on the development of allogeneic (donor-derived) human mesenchymal stem cells (MSCs) that are harvested and grown at its manufacturing facility in Miami, Florida.
LEARN MORE